Low levels of a simple sugar -- A new biomarker for severe MS?

(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) Researchers from the ECRC in Berlin, together with scientists from the United States and Canada, have discovered a sugar molecule whose levels are reduced in the blood of patients with particularly severe multiple sclerosis. Their discovery could pave the way for a new therapeutic approach, the team reports in medical journal JAMA Neurology.